OverviewChartNewsTraderScreen

Soc. Generale Knock-Out PGR/  DE000SY2AAU3  /

EUWAX
2024-08-16  1:51:53 PM Chg.-0.04 Bid3:28:31 PM Ask3:28:31 PM Underlying Strike price Expiration date Option type
1.68EUR -2.33% 1.68
Bid Size: 10,000		 -
Ask Size: -		 Progressive Corporat... 275.2549 USD 2078-12-31 Put
Newsfile Corp 08-12 The Cancer Battle - How Smaller Companies Are Making Big Advancements in Treatments for Solid Tumors
TeleTrader 08-11 Bank of Russia says rates could reach 20%
TeleTrader 08-07 Cori Bush loses Missouri Democratic primary
TeleTrader 08-06 Aramco's Q2 net income down 3.2% to $29.1 billion
TeleTrader 07-29 Putin congratulates Maduro on election victory
TeleTrader 07-27 G20 agrees to work together to tax billionaires
TeleTrader 07-25 Nikki Haley not surprised by Biden's presidential race exit
TeleTrader 07-15 Syrians head to polls for parliamentary elections
TeleTrader 07-13 Progressive Caucus meets with Biden
TeleTrader 07-11 Peskov: NATO nears Russia's borders, could provoke response
TeleTrader 07-08 Lula proud of France's fight against 'extremism'
TeleTrader 07-05 Trudeau, Albanese welcome Labour Party's landslide victory
GlobeNewswire 06-25 argenx Highlights Breadth of Autoimmune Pipeline with New Multifocal Motor Neuropathy Data at 2024 P...
GlobeNewswire 06-25 AskBio Initiates Recruitment to its Phase 2 Parkinson’s Disease Trial
GlobeNewswire 06-24 Enlivex Announces the Dosing of the First Patient in a Randomized, Placebo-Controlled Phase I/II Tri...
GlobeNewswire 06-24 4DMT Announces FDA Clearance of IND Application for 4D-175 Genetic Medicine for the Treatment of Geo...
GlobeNewswire 06-24 Entrada Therapeutics Reports Positive Preliminary Data in Healthy Volunteers from Phase 1 ENTR-601-4...
GlobeNewswire 06-19 Opthea A$55.0m (US$36.9m¹) Retail Entitlement Offer Opens
GlobeNewswire 06-18 Afamelanotide in fair-skinned Parkinson’s patients
GlobeNewswire 06-14 Progressive Reports May 2024 Results
GlobeNewswire 06-13 Dyne Therapeutics Presents New Preclinical Data for its Facioscapulohumeral Muscular Dystrophy Progr...
GlobeNewswire 06-12 Ultragenyx Announces Plans to File for Accelerated Approval of UX111 for the Treatment of Sanfilippo...
GlobeNewswire 06-12 Belite Bio Receives Sakigake (Pioneer Drug) Designation of Tinlarebant for Stargardt Disease in Japa...
GlobeNewswire 06-11 Global Multiple Sclerosis Drugs Market Size Projected to Reach $38 Billion By 2032 as Demand on R&D ...
GlobeNewswire 06-11 Processa Pharmaceuticals Announces Positive Efficacy Results from Preliminary Evaluation of Phase 1b...